Acadia Healthcare (ACHC) Financials

$24.73 -1.66 (-6.29%)

Closing price 04:00 PM Eastern

Extended Trading

$25.58 +0.84 (+3.42%)

As of 07:50 PM Eastern

Annual Income Statements for Acadia Healthcare

This table shows Acadia Healthcare's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	113	6.14	200	-176	109	-672	191	273	-22	256
Consolidated Net Income / (Loss)	111	4.18	200	-175	110	-669	196	280	-16	264
Net Income / (Loss) Continuing Operations	111	4.18	200	57	53	143	208	280	-16	264
Total Pre-Tax Income	165	33	237	67	78	184	276	374	-25	342
Total Operating Income	271	214	413	252	266	309	360	422	50	458
Total Gross Profit	821	1,269	1,300	774	901	935	1,071	1,217	1,356	1,463
Total Revenue	1,830	2,853	2,877	1,905	2,008	2,090	2,314	2,610	2,929	3,154
Operating Revenue	1,830	2,853	2,877	1,905	2,008	2,090	2,314	2,610	2,929	3,154
Total Cost of Revenue	1,009	1,584	1,577	1,131	1,107	1,155	1,244	1,393	1,572	1,691
Operating Cost of Revenue	974	1,542	1,536	1,131	1,107	1,155	1,244	1,393	1,572	1,691
Total Operating Expenses	549	1,055	887	522	635	626	711	795	1,306	1,005
Selling, General & Admin Expense	323	615	642	354	464	470	529	607	671	743
Depreciation Expense	64	135	143	80	88	95	107	118	132	150
Other Operating Expenses / (Income)	115	252	77	36	35	37	39	45	47	48
Impairment Charge	-	0.00	0.00	0.00	27	4.75	24	0.00	9.79	17
Restructuring Charge	37	48	24	30	21	12	13	24	62	47
Other Special Charges / (Income)	11	4.25	0.81	22	-	7.23	0.00	0.00	384	0.00
Total Other Income / (Expense), net	-107	-181	-176	-185	-187	-125	-84	-48	-76	-116
Interest Expense	-	-	-	185	187	158	102	70	82	116
Interest & Investment Income	-107	-181	-176	-	0.00	33	18	21	6.42	0.00
Income Tax Expense	53	29	37	9.91	25	41	68	94	-9.70	77
Net Income / (Loss) Attributable to Noncontrolling Interest	-1.08	-1.97	-0.25	0.26	1.20	2.93	4.93	6.89	6.01	8.87
Basic Earnings per Share	$1.65	$0.07	$2.30	($2.01)	$1.24	($7.65)	$2.15	$3.05	($0.24)	$2.79
Weighted Average Basic Shares Outstanding	68.09M	85.70M	86.95M	87.29M	87.61M	87.88M	88.77M	89.68M	90.95M	91.62M
Diluted Earnings per Share	$1.64	$0.07	$2.30	($2.01)	$1.24	($7.59)	$2.10	$2.98	($0.24)	$2.78
Weighted Average Diluted Shares Outstanding	68.39M	85.97M	87.06M	87.42M	87.82M	88.60M	90.79M	91.56M	90.95M	92.06M
Weighted Average Basic & Diluted Shares Outstanding	68.20M	87.80M	86.90M	87.40M	88.49M	89.04M	89.90M	91.31M	92.29M	92.91M

This table shows Acadia Healthcare's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Income / (Loss) Attributable to Common Shareholders	71	61	66	72	-218	58	76	78	68	33
Consolidated Net Income / (Loss)	73	63	67	74	-216	60	79	81	71	34
Net Income / (Loss) Continuing Operations	73	63	67	74	-216	60	79	81	71	34
Total Pre-Tax Income	97	88	86	96	-287	80	99	106	99	38
Total Operating Income	107	102	106	117	-271	98	126	136	128	68
Total Gross Profit	314	310	313	345	356	342	351	376	387	349
Total Revenue	667	675	704	731	750	743	768	796	816	774
Operating Revenue	667	675	704	731	750	743	768	796	816	774
Total Cost of Revenue	353	366	391	387	394	400	418	420	428	426
Operating Cost of Revenue	353	366	391	387	394	400	418	420	428	426
Total Operating Expenses	207	207	207	227	627	244	224	241	259	281
Selling, General & Admin Expense	155	160	158	166	177	170	173	186	190	194
Depreciation Expense	30	30	32	32	33	35	36	36	38	40
Other Operating Expenses / (Income)	11	12	11	12	12	12	12	12	12	12
Restructuring Charge	11	5.41	6.47	9.07	11	35	2.85	6.09	8.25	30
Total Other Income / (Expense), net	-10	-14	-20	-21	-16	-18	-27	-29	-30	-30
Interest Expense	18	19	-	21	21	-	27	29	30	30
Income Tax Expense	24	25	19	23	-72	20	20	26	27	4.48
Net Income / (Loss) Attributable to Noncontrolling Interest	1.95	2.02	0.54	1.25	2.19	2.03	2.39	2.34	3.24	0.91
Basic Earnings per Share	$0.79	$0.69	$0.73	$0.79	($2.39)	$0.63	$0.84	$0.86	$0.74	$0.35
Weighted Average Basic Shares Outstanding	89.83M	89.68M	90.10M	91.04M	91.17M	90.95M	91.36M	91.63M	91.72M	91.62M
Diluted Earnings per Share	$0.78	$0.65	$0.72	$0.79	($2.39)	$0.64	$0.83	$0.85	$0.74	$0.36
Weighted Average Diluted Shares Outstanding	91.72M	91.56M	91.39M	91.55M	91.17M	90.95M	92.01M	92.04M	92.19M	92.06M
Weighted Average Basic & Diluted Shares Outstanding	90.98M	91.31M	92.03M	92.17M	92.22M	92.29M	92.77M	92.87M	92.89M	92.91M

This table details how cash moves in and out of Acadia Healthcare's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Change in Cash & Equivalents	-83	46	2.98	-14	49	325	-245	-36	2.42	-24
Net Cash From Operating Activities	240	361	400	414	333	659	374	381	462	130
Net Cash From Continuing Operating Activities	242	372	401	226	183	503	374	0.00	0.00	0.00
Net Income / (Loss) Continuing Operations	111	4.18	200	57	53	143	208	280	-16	264
Consolidated Net Income / (Loss)	111	4.18	200	-175	110	-669	196	280	-16	264
Net Income / (Loss) Discontinued Operations	-0.11	-	-	-233	57	-812	-13	0.00	0.00	0.00
Depreciation Expense	64	135	143	80	88	95	107	118	132	150
Amortization Expense	6.71	10	9.86	10	12	13	4.07	3.26	3.32	4.09
Non-Cash Adjustments To Reconcile Net Income	35	216	36	58	48	122	49	-6.76	421	117
Changes in Operating Assets and Liabilities, net	26	6.53	13	19	-18	130	6.40	-14	-78	-406
Net Cash From Discontinued Operating Activities	-1.74	-10	-1.69	188	149	156	0.25	0.00	0.00	0.00
Net Cash From Investing Activities	-884	-660	-337	-361	-201	-282	1,013	-306	-397	-736
Net Cash From Continuing Investing Activities	-884	-660	-337	-276	-148	-238	0.00	0.00	0.00	0.00
Purchase of Property, Plant & Equipment	-303	-348	-274	-253	-233	-225	-245	-296	-424	-690
Acquisitions	-575	-683	-18	0.00	-45	0.00	-139	-9.51	-0.35	-54
Purchase of Investments	-1.93	-	-	-	105	0.00	-85	0.00	0.00	0.00
Sale of Property, Plant & Equipment	-	-	5.25	0.00	12	0.09	3.49	7.07	29	10
Divestitures	-	373	-	-	0.00	0.00	1,511	0.00	0.00	0.00
Other Investing Activities, net	-5.10	-2.47	-49	-23	13	-13	-33	-7.25	-2.16	-2.98
Net Cash From Discontinued Investing Activities	-	-	-	-85	-53	-44	0.00	0.00	0.00	0.00
Net Cash From Financing Activities	564	359	-60	-67	-62	-51	-1,637	-111	-63	583
Net Cash From Continuing Financing Activities	564	359	-60	-64	-59	-48	0.00	0.00	0.00	0.00
Repayment of Debt	-1,378	-1,976	-57	-62	-134	-1,073	-2,581	-114	-56	-73
Repurchase of Common Equity	-	-8.85	-3.46	-3.41	-1.65	0.18	16	-12	-44	0.00
Payment of Dividends	-	-	0.00	0.00	-0.15	-0.92	-1.59	-1.00	-5.11	-2.97
Issuance of Debt	1,618	1,659	0.69	0.83	77	1,025	925	0.00	40	655
Issuance of Common Equity	331	685	-	-	-	0.00	4.54	15	2.96	5.18
Net Cash From Discontinued Financing Activities	-	-	-	-3.09	-2.47	-3.25	0.00	0.00	0.00	0.00
Effect of Exchange Rate Changes	-2.36	-14	-	-	3.55	-	-	-	-	0.00
Other Net Changes in Cash	-	-	-	-	-25	-	-	-	-	0.00
Cash Interest Paid	87	161	159	175	173	138	94	66	81	113
Cash Income Taxes Paid	-	-	-	-	32	-	79	86	66	28

This table details how cash moves in and out of Acadia Healthcare's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Change in Cash & Equivalents	-35	4.23	-34	48	-13	0.48	-23	-0.14	4.98	-5.84
Net Cash From Operating Activities	41	114	44	164	138	116	-321	171	163	117
Net Cash From Continuing Operating Activities	267	-267	44	164	138	-346	-321	171	163	-13
Net Income / (Loss) Continuing Operations	73	63	67	74	-216	60	79	81	71	34
Consolidated Net Income / (Loss)	73	63	67	74	-216	60	79	81	71	34
Depreciation Expense	30	30	32	32	33	35	36	36	38	40
Amortization Expense	0.82	0.82	0.82	0.83	0.83	0.84	1.02	1.02	1.03	1.03
Non-Cash Adjustments To Reconcile Net Income	-22	1.70	8.72	16	398	-2.29	22	-7.46	20	83
Changes in Operating Assets and Liabilities, net	-40	18	-63	41	-79	23	-459	61	33	-40
Net Cash From Investing Activities	-78	-92	-67	-91	-129	-110	-185	-155	-193	-203
Net Cash From Continuing Investing Activities	-78	214	-67	-91	-129	287	-185	-155	-193	533
Purchase of Property, Plant & Equipment	-76	-87	-67	-91	-128	-139	-142	-154	-190	-203
Sale of Property, Plant & Equipment	0.11	5.29	0.41	0.21	0.01	29	9.06	1.15	0.02	0.21
Other Investing Activities, net	-1.79	-0.45	-0.79	-0.15	-0.99	-0.23	-0.91	-2.03	-0.00	-0.04
Net Cash From Financing Activities	2.04	-17	-11	-25	-21	-5.65	483	-16	35	81
Net Cash From Continuing Financing Activities	2.04	94	-11	-25	-21	57	484	-17	35	-502
Repayment of Debt	-5.30	-15	-5.30	-25	-20	-5.31	-27	-15	-15	-15
Repurchase of Common Equity	2.33	-4.18	-48	1.77	0.71	0.86	-	-	0.84	0.82
Issuance of Debt	-	-	40	-	-	-	510	-	50	95
Issuance of Common Equity	5.17	2.18	1.66	0.86	0.02	0.42	2.28	0.69	0.53	1.68

This table presents Acadia Healthcare's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	4,279	6,025	6,425	6,173	6,879	6,499	4,768	4,988	5,359	5,957
Total Current Assets	295	428	472	450	542	2,523	495	506	596	577
Cash & Equivalents	11	57	67	51	100	379	134	98	100	76
Accounts Receivable	217	263	297	318	289	274	281	322	361	365
Other Current Assets	67	108	107	82	65	61	80	86	134	136
Plant, Property, & Equipment, net	1,709	2,704	3,048	3,108	1,500	1,623	1,771	1,952	2,267	2,853
Total Noncurrent Assets	2,275	2,893	2,905	2,614	4,837	2,353	2,502	2,530	2,496	2,526
Goodwill	2,128	2,681	2,751	2,396	2,085	2,105	2,200	2,223	2,226	2,265
Intangible Assets	60	83	87	89	69	69	70	76	73	70
Noncurrent Deferred & Refundable Income Taxes	49	3.78	3.73	3.47	3.34	3.21	3.08	2.95	6.66	21
Other Noncurrent Operating Assets	39	125	63	125	153	176	229	228	190	170
Total Liabilities & Shareholders' Equity	4,279	6,025	6,425	6,173	6,879	6,499	4,768	4,988	5,359	5,957
Total Liabilities	2,588	3,839	3,829	3,810	4,341	4,545	2,185	2,087	2,471	2,766
Total Current Liabilities	290	343	377	416	464	1,308	405	388	886	578
Short-Term Debt	45	35	35	34	44	153	19	21	29	77
Accounts Payable	91	80	102	118	90	88	99	105	156	233
Accrued Expenses	73	123	141	151	69	178	126	111	532	88
Current Employee Benefit Liabilities	81	105	99	113	94	125	138	125	142	155
Other Current Liabilities	-	-	-	0.00	18	104	23	26	26	25
Total Noncurrent Liabilities	2,298	3,496	3,452	3,394	3,877	3,236	1,780	1,699	1,585	2,188
Long-Term Debt	2,195	3,253	3,205	3,159	3,105	2,969	1,479	1,365	1,343	1,880
Noncurrent Deferred & Payable Income Tax Liabilities	24	79	80	80	23	50	74	93	1.93	84
Other Noncurrent Operating Liabilities	79	165	166	154	262	217	111	241	241	224
Redeemable Noncontrolling Interest	8.06	18	22	29	33	55	65	88	106	117
Total Equity & Noncontrolling Interests	1,683	2,168	2,573	2,333	2,505	1,899	2,517	2,813	2,782	3,074
Total Preferred & Common Equity	1,683	2,168	2,573	2,333	2,505	1,899	2,517	2,813	2,782	3,074
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,683	2,168	2,573	2,333	2,505	1,899	2,517	2,813	2,782	3,074
Common Stock	1,574	2,497	2,518	2,543	2,559	2,581	2,637	2,659	2,650	2,686
Retained Earnings	214	220	429	253	362	-310	-120	153	132	387

This table presents Acadia Healthcare's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Total Assets	4,943	5,044	5,150	5,346	5,517	5,678	5,870
Total Current Assets	522	538	579	703	611	645	652
Cash & Equivalents	93	64	112	100	77	77	82
Accounts Receivable	316	346	346	363	386	389	384
Other Current Assets	112	128	121	241	147	179	186
Plant, Property, & Equipment, net	1,909	1,998	2,074	2,146	2,376	2,498	2,680
Total Noncurrent Assets	2,512	2,508	2,497	2,497	2,530	2,535	2,539
Goodwill	2,208	2,223	2,223	2,226	2,261	2,261	2,265
Intangible Assets	76	76	72	74	73	73	73
Noncurrent Deferred & Refundable Income Taxes	2.98	2.92	2.89	2.85	2.78	2.74	2.71
Other Noncurrent Operating Assets	226	206	200	195	193	197	198
Total Liabilities & Shareholders' Equity	4,943	5,044	5,150	5,346	5,517	5,678	5,870
Total Liabilities	2,111	2,114	2,139	2,536	2,542	2,613	2,724
Total Current Liabilities	401	378	432	865	482	547	610
Short-Term Debt	21	21	24	27	61	67	72
Accounts Payable	116	126	149	150	156	160	201
Accrued Expenses	128	110	122	540	120	159	168
Current Employee Benefit Liabilities	110	95	111	122	118	135	141
Other Current Liabilities	26	26	26	26	27	27	27
Total Noncurrent Liabilities	1,710	1,736	1,706	1,671	2,060	2,067	2,115
Long-Term Debt	1,379	1,400	1,372	1,350	1,794	1,775	1,805
Noncurrent Deferred & Payable Income Tax Liabilities	94	93	93	70	16	37	54
Other Noncurrent Operating Liabilities	119	244	241	251	250	255	256
Redeemable Noncontrolling Interest	88	90	91	98	109	112	115
Total Equity & Noncontrolling Interests	2,744	2,840	2,921	2,713	2,866	2,953	3,032
Total Preferred & Common Equity	2,744	2,840	2,921	2,713	2,866	2,953	3,032
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	2,744	2,840	2,921	2,713	2,866	2,953	3,032
Common Stock	2,651	2,620	2,629	2,639	2,658	2,666	2,677
Retained Earnings	92	219	292	74	208	287	355

This table displays calculated financial ratios and metrics derived from Acadia Healthcare's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	77.50%	55.92%	0.86%	-33.80%	5.44%	4.06%	10.74%	12.79%	12.20%	7.69%
EBITDA Growth	62.55%	5.25%	57.26%	-39.41%	6.68%	14.04%	12.79%	15.56%	-65.77%	228.96%
EBIT Growth	55.70%	-21.07%	92.65%	-38.97%	5.47%	16.32%	16.31%	17.51%	-88.08%	810.20%
NOPAT Growth	59.52%	-85.20%	1,181.39%	-38.24%	-15.92%	33.26%	12.72%	16.49%	-88.85%	905.92%
Net Income Growth	34.24%	-96.25%	4,679.43%	-187.92%	162.75%	-707.69%	129.22%	43.19%	-105.59%	1,788.81%
EPS Growth	9.33%	-95.73%	3,185.71%	-187.39%	161.69%	-712.10%	127.67%	41.90%	-108.05%	1,258.33%
Operating Cash Flow Growth	108.53%	50.36%	10.54%	3.63%	-19.60%	97.90%	-43.16%	1.63%	21.49%	-71.95%
Free Cash Flow Firm Growth	-184.17%	21.50%	99.75%	12,931.96%	334.99%	-85.57%	-181.01%	178.27%	-65.82%	-957.62%
Invested Capital Growth	110.04%	38.15%	6.49%	-4.56%	-34.46%	-1.64%	14.50%	3.10%	-0.71%	21.93%
Revenue Q/Q Growth	12.54%	7.90%	0.69%	-36.56%	2.31%	69.94%	2.31%	3.24%	2.36%	1.01%
EBITDA Q/Q Growth	13.31%	6.95%	3.88%	-41.25%	12.04%	45.26%	18.34%	-2.59%	0.80%	-4.08%
EBIT Q/Q Growth	13.25%	3.44%	4.41%	-39.43%	14.80%	29.68%	24.88%	-3.70%	-6.97%	-6.22%
NOPAT Q/Q Growth	12.88%	269.60%	12.28%	-46.67%	47.17%	145.42%	22.80%	-4.48%	-6.97%	-4.21%
Net Income Q/Q Growth	11.86%	226.62%	16.50%	-177.74%	152.17%	-749.52%	129.70%	-2.90%	-27.61%	-9.02%
EPS Q/Q Growth	7.89%	-30.00%	17.35%	-177.61%	151.24%	-771.68%	127.93%	-3.87%	-4.35%	-9.15%
Operating Cash Flow Q/Q Growth	27.65%	0.98%	7.08%	-0.08%	-2.50%	11.36%	-19.15%	4.30%	0.60%	0.31%
Free Cash Flow Firm Q/Q Growth	-8.34%	31.61%	-100.74%	110.23%	348.85%	55.72%	-112.58%	197.04%	-68.65%	-15.38%
Invested Capital Q/Q Growth	4.19%	-8.11%	1.20%	-6.30%	-34.82%	-34.77%	8.94%	-1.58%	1.77%	2.65%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	44.86%	44.48%	45.19%	40.63%	44.86%	44.76%	46.26%	46.62%	46.31%	46.38%
EBITDA Margin	18.68%	12.61%	19.66%	17.99%	18.21%	19.95%	20.32%	20.82%	6.35%	19.40%
Operating Margin	14.84%	7.51%	14.35%	13.23%	13.23%	14.79%	15.53%	16.18%	1.72%	14.53%
EBIT Margin	14.84%	7.51%	14.35%	13.23%	13.23%	14.79%	15.53%	16.18%	1.72%	14.53%
Profit (Net Income) Margin	6.09%	0.15%	6.94%	-9.21%	5.48%	-32.02%	8.45%	10.73%	-0.53%	8.39%
Tax Burden Percent	67.66%	12.67%	84.29%	-260.38%	140.47%	-364.10%	70.92%	74.85%	61.75%	77.36%
Interest Burden Percent	60.68%	15.38%	57.36%	26.75%	29.50%	59.47%	76.71%	88.56%	-50.37%	74.61%
Effective Tax Rate	32.40%	87.33%	15.71%	14.70%	32.00%	22.09%	24.50%	25.15%	0.00%	22.64%
Return on Invested Capital (ROIC)	6.34%	0.58%	6.22%	3.81%	3.97%	6.73%	7.13%	7.66%	0.84%	7.68%
ROIC Less NNEP Spread (ROIC-NNEP)	1.86%	-0.26%	1.59%	-8.55%	0.61%	-61.61%	2.20%	5.05%	-3.13%	1.97%
Return on Net Nonoperating Assets (RNNOA)	2.33%	-0.37%	2.13%	-10.89%	0.53%	-36.52%	1.49%	2.55%	-1.39%	1.02%
Return on Equity (ROE)	8.67%	0.22%	8.35%	-7.08%	4.49%	-29.79%	8.62%	10.21%	-0.54%	8.70%
Cash Return on Invested Capital (CROIC)	-64.64%	-31.46%	-0.07%	8.48%	45.60%	8.38%	-6.38%	4.61%	1.56%	-12.08%
Operating Return on Assets (OROA)	8.37%	4.16%	6.63%	4.00%	4.07%	4.62%	6.38%	8.66%	0.97%	8.10%
Return on Assets (ROA)	3.44%	0.08%	3.21%	-2.79%	1.69%	-10.00%	3.47%	5.74%	-0.30%	4.67%
Return on Common Equity (ROCE)	8.64%	0.21%	8.28%	-7.01%	4.44%	-29.20%	8.39%	9.93%	-0.52%	8.38%
Return on Equity Simple (ROE_SIMPLE)	6.62%	0.19%	7.76%	-7.52%	4.40%	-35.23%	7.77%	9.96%	-0.56%	8.60%
Net Operating Profit after Tax (NOPAT)	184	27	348	215	181	241	271	316	35	355
NOPAT Margin	10.03%	0.95%	12.09%	11.28%	9.00%	11.52%	11.73%	12.11%	1.20%	11.24%
Net Nonoperating Expense Percent (NNEP)	4.48%	0.84%	4.63%	12.36%	3.35%	68.34%	4.94%	2.61%	3.98%	5.71%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	7.53%	0.85%	7.05%
Cost of Revenue to Revenue	55.14%	55.52%	54.81%	59.37%	55.14%	55.24%	53.74%	53.38%	53.69%	53.62%
SG&A Expenses to Revenue	17.67%	21.57%	22.33%	18.57%	23.08%	22.49%	22.85%	23.27%	22.91%	23.56%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	30.02%	36.97%	30.84%	27.41%	31.63%	29.97%	30.72%	30.44%	44.59%	31.85%
Earnings before Interest and Taxes (EBIT)	271	214	413	252	266	309	360	422	50	458
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	342	360	566	343	366	417	470	543	186	612
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.66	1.34	1.11	0.97	1.17	2.35	2.17	2.66	2.58	1.20
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	8.37	0.00	22.07	14.57	14.85	4.98
Price to Revenue (P/Rev)	2.45	1.02	1.00	1.19	1.47	2.14	2.36	2.87	2.45	1.17
Price to Earnings (P/E)	39.78	471.48	14.35	0.00	27.01	0.00	28.64	27.42	0.00	14.41
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	2.51%	0.21%	6.97%	0.00%	3.70%	0.00%	3.49%	3.65%	0.00%	6.94%
Enterprise Value to Invested Capital (EV/IC)	1.71	1.13	1.05	0.99	1.67	2.05	1.72	2.12	2.06	1.12
Enterprise Value to Revenue (EV/Rev)	3.67	2.15	2.11	2.86	3.00	3.48	3.03	3.40	2.92	1.80
Enterprise Value to EBITDA (EV/EBITDA)	19.65	17.08	10.72	15.88	16.48	17.44	14.89	16.31	45.95	9.28
Enterprise Value to EBIT (EV/EBIT)	24.73	28.68	14.68	21.60	22.67	23.53	19.48	20.99	169.79	12.40
Enterprise Value to NOPAT (EV/NOPAT)	36.59	226.30	17.42	25.32	33.34	30.20	25.81	28.04	242.55	16.02
Enterprise Value to Operating Cash Flow (EV/OCF)	27.93	17.00	15.17	13.14	18.10	11.04	18.71	23.30	18.49	43.80
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	11.39	2.90	24.24	0.00	46.61	131.48	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.33	1.50	1.25	1.35	1.24	1.60	0.62	0.48	0.48	0.61
Long-Term Debt to Equity	1.30	1.49	1.24	1.34	1.22	1.52	0.62	0.47	0.46	0.59
Financial Leverage	1.25	1.41	1.34	1.27	0.86	0.59	0.68	0.50	0.44	0.52
Leverage Ratio	2.52	2.66	2.60	2.54	2.66	2.98	2.48	1.78	1.79	1.86
Compound Leverage Factor	1.53	0.41	1.49	0.68	0.79	1.77	1.90	1.58	-0.90	1.39
Debt to Total Capital	56.99%	60.07%	55.52%	57.48%	55.37%	61.50%	38.46%	32.33%	32.21%	38.01%
Short-Term Debt to Total Capital	1.15%	0.64%	0.60%	0.61%	0.77%	3.02%	0.44%	0.50%	0.69%	1.49%
Long-Term Debt to Total Capital	55.84%	59.43%	54.93%	56.87%	54.60%	58.48%	38.02%	31.83%	31.52%	36.52%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.20%	0.32%	0.38%	0.52%	0.58%	1.09%	1.56%	2.06%	2.48%	2.28%
Common Equity to Total Capital	42.81%	39.61%	44.09%	42.00%	44.05%	37.41%	59.98%	65.61%	65.31%	59.71%
Debt to EBITDA	6.56	9.14	5.73	9.32	8.61	7.49	3.43	2.55	7.37	3.20
Net Debt to EBITDA	6.52	8.98	5.61	9.17	8.34	6.58	3.15	2.37	6.84	3.07
Long-Term Debt to EBITDA	6.42	9.04	5.67	9.22	8.49	7.12	3.39	2.51	7.22	3.07
Debt to NOPAT	12.21	121.08	9.31	14.86	17.43	12.97	5.95	4.38	38.92	5.52
Net Debt to NOPAT	12.15	118.98	9.12	14.63	16.88	11.39	5.45	4.07	36.08	5.30
Long-Term Debt to NOPAT	11.96	119.80	9.21	14.70	17.19	12.33	5.88	4.32	38.09	5.30
Altman Z-Score	1.75	1.11	1.22	0.86	0.91	1.23	2.22	3.03	2.29	1.67
Noncontrolling Interest Sharing Ratio	0.31%	0.67%	0.84%	1.03%	1.26%	1.97%	2.66%	2.80%	3.35%	3.67%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.02	1.25	1.25	1.08	1.17	1.93	1.22	1.30	0.67	1.00
Quick Ratio	0.79	0.93	0.97	0.89	0.84	0.50	1.03	1.08	0.52	0.76
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-1,871	-1,468	-3.72	478	2,078	300	-243	190	65	-558
Operating Cash Flow to CapEx	79.43%	103.80%	148.58%	163.55%	150.69%	292.97%	155.18%	131.65%	117.13%	19.07%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	2.59	11.09	1.90	-2.39	2.73	0.79	-4.79
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	2.24	1.78	4.17	3.68	5.46	5.63	1.11
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.87	0.60	2.74	1.31	1.31	0.82	-4.73
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.56	0.55	0.46	0.30	0.31	0.31	0.41	0.54	0.57	0.56
Accounts Receivable Turnover	10.92	11.89	10.27	6.19	6.62	7.43	8.34	8.65	8.56	8.68
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	1.32	1.29	1.00	0.62	0.87	1.34	1.36	1.40	1.39	1.23
Accounts Payable Turnover	14.41	18.48	17.30	10.28	10.65	12.97	13.35	13.71	12.06	8.70
Days Sales Outstanding (DSO)	33.42	30.70	35.54	58.93	55.15	49.11	43.75	42.21	42.62	42.05
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	25.33	19.75	21.10	35.51	34.28	28.15	27.35	26.63	30.28	41.96
Cash Conversion Cycle (CCC)	8.08	10.96	14.44	23.42	20.87	20.96	16.41	15.59	12.34	0.09
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	3,921	5,416	5,768	5,505	3,608	3,549	4,063	4,189	4,159	5,071
Invested Capital Turnover	0.63	0.61	0.51	0.34	0.44	0.58	0.61	0.63	0.70	0.68
Increase / (Decrease) in Invested Capital	2,054	1,496	352	-263	-1,897	-59	514	126	-30	912
Enterprise Value (EV)	6,715	6,145	6,062	5,441	6,025	7,272	7,005	8,866	8,548	5,681
Market Capitalization	4,478	2,896	2,867	2,269	2,942	4,473	5,459	7,489	7,171	3,683
Book Value per Share	$23.48	$24.77	$29.29	$26.44	$28.29	$21.34	$27.99	$30.92	$30.17	$33.09
Tangible Book Value per Share	($7.04)	($6.82)	($3.02)	($1.72)	$3.97	($3.08)	$2.75	$5.65	$5.23	$7.95
Total Capital	3,932	5,473	5,835	5,556	5,688	5,077	4,197	4,287	4,259	5,148
Total Debt	2,241	3,288	3,240	3,193	3,149	3,122	1,614	1,386	1,372	1,957
Total Long-Term Debt	2,195	3,253	3,205	3,159	3,105	2,969	1,595	1,365	1,343	1,880
Net Debt	2,230	3,231	3,173	3,143	3,050	2,744	1,480	1,288	1,272	1,881
Capital Expenditures (CapEx)	303	348	269	253	221	225	241	289	395	680
Debt-free, Cash-free Net Working Capital (DFCFNWC)	39	63	62	18	23	990	-25	41	-361	0.08
Debt-free Net Working Capital (DFNWC)	50	120	129	68	122	1,369	109	139	-261	76
Net Working Capital (NWC)	4.53	85	94	34	79	1,215	90	118	-290	-0.43
Net Nonoperating Expense (NNE)	72	23	148	390	71	910	76	36	51	90
Net Nonoperating Obligations (NNO)	2,230	3,231	3,173	3,143	1,069	1,594	1,480	1,288	1,272	1,881
Total Depreciation and Amortization (D&A)	70	145	153	91	100	108	111	121	136	154
Debt-free, Cash-free Net Working Capital to Revenue	2.11%	2.20%	2.14%	0.93%	1.13%	47.37%	-1.08%	1.59%	-12.31%	0.00%
Debt-free Net Working Capital to Revenue	2.73%	4.20%	4.48%	3.58%	6.09%	65.49%	4.70%	5.33%	-8.90%	2.42%
Net Working Capital to Revenue	0.25%	2.98%	3.27%	1.79%	3.92%	58.15%	3.90%	4.51%	-9.89%	-0.01%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.65	$0.07	$2.30	($2.01)	$1.24	($7.65)	$2.15	$3.05	($0.24)	$2.79
Adjusted Weighted Average Basic Shares Outstanding	68.09M	85.70M	86.95M	87.29M	87.61M	87.88M	88.77M	89.68M	90.95M	91.62M
Adjusted Diluted Earnings per Share	$1.64	$0.07	$2.30	($2.01)	$1.24	($7.59)	$2.10	$2.98	($0.24)	$2.78
Adjusted Weighted Average Diluted Shares Outstanding	68.39M	85.97M	87.06M	87.29M	87.82M	88.60M	90.79M	91.56M	90.95M	92.06M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	($2.01)	$1.24	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	87.22M	87.55M	87.95M	88.46M	88.49M	89.04M	89.90M	91.31M	92.29M	92.91M
Normalized Net Operating Profit after Tax (NOPAT)	216	187	369	259	214	259	299	334	355	404
Normalized NOPAT Margin	11.78%	6.55%	12.83%	13.60%	10.63%	12.41%	12.94%	12.79%	12.11%	12.81%
Pre Tax Income Margin	9.00%	1.16%	8.23%	3.54%	3.90%	8.79%	11.92%	14.33%	-0.87%	10.84%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	1.37	1.42	1.95	3.54	6.06	0.61	3.94
NOPAT to Interest Expense	0.00	0.00	0.00	1.16	0.96	1.52	2.67	4.53	0.43	3.05
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	-0.01	0.24	0.53	1.16	1.91	-4.19	-1.91
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	-0.21	-0.21	0.10	0.30	0.39	-4.38	-2.80
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.14%	-0.14%	0.81%	0.36%	-32.61%	1.12%
Augmented Payout Ratio	0.00%	211.83%	1.73%	-1.94%	1.64%	-0.11%	-7.52%	4.54%	-315.70%	1.12%

This table displays calculated financial ratios and metrics derived from Acadia Healthcare's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	13.47%	13.79%	14.21%	12.22%	12.54%	10.00%	9.06%	8.85%	8.70%	4.23%
EBITDA Growth	6.34%	-9.77%	10.58%	1.74%	-271.85%	1.11%	18.39%	15.00%	170.57%	-19.33%
EBIT Growth	6.37%	-13.69%	11.09%	-0.28%	-352.30%	-3.69%	19.33%	15.58%	147.40%	-30.86%
NOPAT Growth	0.53%	-16.83%	10.60%	1.79%	-334.78%	0.39%	22.36%	15.03%	149.03%	-18.38%
Net Income Growth	7.58%	-11.71%	7.51%	-10.23%	-395.05%	-5.37%	18.35%	9.88%	133.11%	-43.89%
EPS Growth	6.85%	-15.58%	7.46%	-10.23%	-406.41%	-1.54%	15.28%	7.59%	130.96%	-43.75%
Operating Cash Flow Growth	-62.73%	16.04%	-42.17%	9.76%	235.94%	2.43%	-823.48%	4.51%	18.33%	0.34%
Free Cash Flow Firm Growth	-124.91%	87.64%	11.42%	80.17%	95.45%	296.10%	-69.79%	-500.93%	-3,648.20%	-924.39%
Invested Capital Growth	14.13%	3.10%	7.46%	3.89%	-3.98%	-0.71%	10.88%	12.40%	20.88%	21.93%
Revenue Q/Q Growth	2.30%	1.28%	4.29%	3.84%	2.60%	-1.00%	3.40%	3.64%	2.46%	-5.08%
EBITDA Q/Q Growth	-6.62%	-3.37%	3.63%	8.80%	-257.73%	156.86%	21.34%	5.68%	-3.21%	-35.00%
EBIT Q/Q Growth	-8.69%	-4.86%	3.34%	11.07%	-331.04%	136.32%	28.03%	7.58%	-5.26%	-47.02%
NOPAT Q/Q Growth	-8.07%	-9.32%	12.01%	9.01%	-312.04%	138.77%	36.53%	2.48%	-9.63%	-35.45%
Net Income Q/Q Growth	-10.85%	-13.55%	5.41%	10.50%	-393.04%	127.73%	31.82%	2.60%	-11.69%	-53.02%
EPS Q/Q Growth	-11.36%	-16.67%	10.77%	9.72%	-402.53%	126.78%	29.69%	2.41%	-12.94%	-51.35%
Operating Cash Flow Q/Q Growth	-72.50%	176.69%	-60.89%	268.78%	-15.82%	-15.63%	-376.25%	153.27%	-4.69%	-28.46%
Free Cash Flow Firm Q/Q Growth	-23.65%	88.19%	-309.10%	66.82%	71.65%	609.51%	-454.21%	-17.43%	-76.85%	-12.06%
Invested Capital Q/Q Growth	2.95%	-1.58%	2.34%	0.20%	-4.86%	1.77%	14.29%	1.57%	2.32%	2.65%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	47.12%	45.85%	44.46%	47.13%	47.47%	46.10%	45.64%	47.27%	47.51%	45.03%
EBITDA Margin	20.67%	19.72%	19.60%	20.53%	-31.57%	18.13%	21.28%	21.70%	20.49%	14.03%
Operating Margin	16.12%	15.14%	15.00%	16.04%	-36.13%	13.26%	16.41%	17.04%	15.75%	8.79%
EBIT Margin	16.12%	15.14%	15.00%	16.04%	-36.13%	13.26%	16.41%	17.04%	15.75%	8.79%
Profit (Net Income) Margin	10.96%	9.35%	9.45%	10.06%	-28.72%	8.04%	10.26%	10.15%	8.75%	4.33%
Tax Burden Percent	75.23%	71.70%	77.72%	76.27%	74.99%	74.73%	79.69%	75.91%	72.41%	88.22%
Interest Burden Percent	90.37%	86.15%	81.07%	82.18%	106.01%	81.21%	78.41%	78.50%	76.71%	55.83%
Effective Tax Rate	24.77%	28.30%	22.28%	23.73%	0.00%	25.27%	20.31%	24.09%	27.59%	11.78%
Return on Invested Capital (ROIC)	7.68%	6.87%	7.60%	8.06%	-17.35%	6.95%	8.66%	8.67%	7.89%	5.30%
ROIC Less NNEP Spread (ROIC-NNEP)	7.09%	6.13%	6.45%	6.87%	-19.25%	5.87%	7.28%	7.21%	6.48%	3.62%
Return on Net Nonoperating Assets (RNNOA)	3.54%	3.10%	3.13%	3.20%	-9.22%	2.60%	3.86%	3.62%	3.34%	1.88%
Return on Equity (ROE)	11.21%	9.96%	10.73%	11.27%	-26.56%	9.55%	12.52%	12.29%	11.23%	7.18%
Cash Return on Invested Capital (CROIC)	-4.91%	4.61%	0.63%	3.90%	4.97%	1.56%	-9.22%	-10.31%	-10.71%	-12.08%
Operating Return on Assets (OROA)	8.54%	8.10%	8.19%	8.88%	-20.09%	7.50%	9.30%	9.62%	8.77%	4.90%
Return on Assets (ROA)	5.81%	5.00%	5.16%	5.57%	-15.97%	4.55%	5.81%	5.73%	4.87%	2.41%
Return on Common Equity (ROCE)	10.90%	9.68%	10.42%	10.94%	-25.69%	9.23%	12.10%	11.88%	10.83%	6.91%
Return on Equity Simple (ROE_SIMPLE)	10.51%	0.00%	10.03%	9.46%	-0.45%	0.00%	-0.12%	0.13%	9.59%	0.00%
Net Operating Profit after Tax (NOPAT)	81	73	82	89	-190	74	100	103	93	60
NOPAT Margin	12.12%	10.85%	11.66%	12.24%	-25.29%	9.91%	13.08%	12.93%	11.41%	7.76%
Net Nonoperating Expense Percent (NNEP)	0.59%	0.73%	1.15%	1.19%	1.91%	1.08%	1.38%	1.45%	1.41%	1.68%
Return On Investment Capital (ROIC_SIMPLE)	-	1.75%	-	-	-	1.77%	-	-	-	1.19%
Cost of Revenue to Revenue	52.88%	54.15%	55.54%	52.87%	52.53%	53.90%	54.36%	52.73%	52.49%	54.97%
SG&A Expenses to Revenue	23.24%	23.71%	22.43%	22.68%	23.55%	22.93%	22.58%	23.32%	23.33%	25.05%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	31.00%	30.71%	29.46%	31.09%	83.60%	32.84%	29.23%	30.23%	31.75%	36.24%
Earnings before Interest and Taxes (EBIT)	107	102	106	117	-271	98	126	136	128	68
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	138	133	138	150	-237	135	163	173	167	109
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.59	2.66	2.32	2.51	2.39	2.58	2.55	2.12	1.94	1.20
Price to Tangible Book Value (P/TBV)	15.44	14.57	12.21	11.70	15.70	14.85	13.74	10.14	8.49	4.98
Price to Revenue (P/Rev)	2.81	2.87	2.45	2.64	2.27	2.45	2.44	2.05	1.89	1.17
Price to Earnings (P/E)	25.16	27.42	23.70	27.09	0.00	0.00	0.00	0.00	20.98	14.41
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	3.97%	3.65%	4.22%	3.69%	0.00%	0.00%	0.00%	0.00%	4.77%	6.94%
Enterprise Value to Invested Capital (EV/IC)	2.02	2.12	1.88	2.03	1.92	2.06	1.93	1.69	1.58	1.12
Enterprise Value to Revenue (EV/Rev)	3.41	3.40	2.98	3.13	2.75	2.92	3.07	2.66	2.50	1.80
Enterprise Value to EBITDA (EV/EBITDA)	15.44	16.31	14.45	15.56	42.57	45.95	43.49	34.81	12.22	9.28
Enterprise Value to EBIT (EV/EBIT)	19.64	20.99	18.58	20.12	145.15	169.79	129.92	91.44	15.96	12.40
Enterprise Value to NOPAT (EV/NOPAT)	26.02	28.04	24.83	26.74	207.36	242.55	185.60	130.63	21.07	16.02
Enterprise Value to Operating Cash Flow (EV/OCF)	23.61	23.30	23.11	23.99	17.09	18.49	95.12	78.27	60.31	43.80
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	46.61	306.28	52.92	37.88	131.48	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.54	0.48	0.49	0.46	0.49	0.48	0.62	0.60	0.60	0.61
Long-Term Debt to Equity	0.53	0.47	0.48	0.46	0.48	0.46	0.60	0.58	0.57	0.59
Financial Leverage	0.50	0.50	0.48	0.47	0.48	0.44	0.53	0.50	0.52	0.52
Leverage Ratio	1.79	1.78	1.77	1.74	1.82	1.79	1.79	1.78	1.88	1.86
Compound Leverage Factor	1.62	1.53	1.44	1.43	1.93	1.45	1.40	1.40	1.44	1.04
Debt to Total Capital	34.90%	32.33%	32.66%	31.68%	32.88%	32.21%	38.41%	37.53%	37.36%	38.01%
Short-Term Debt to Total Capital	0.49%	0.50%	0.49%	0.54%	0.63%	0.69%	1.27%	1.36%	1.43%	1.49%
Long-Term Debt to Total Capital	34.41%	31.83%	32.17%	31.13%	32.24%	31.52%	37.14%	36.17%	35.93%	36.52%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	2.03%	2.06%	2.08%	2.06%	2.33%	2.48%	2.26%	2.28%	2.28%	2.28%
Common Equity to Total Capital	63.07%	65.61%	65.26%	66.27%	64.79%	65.31%	59.32%	60.19%	60.36%	59.71%
Debt to EBITDA	2.72	2.55	2.55	2.50	7.46	7.37	8.78	7.87	2.94	3.20
Net Debt to EBITDA	2.55	2.37	2.44	2.30	6.92	6.84	8.41	7.54	2.81	3.07
Long-Term Debt to EBITDA	2.68	2.51	2.51	2.45	7.32	7.22	8.49	7.59	2.83	3.07
Debt to NOPAT	4.59	4.38	4.39	4.29	36.34	38.92	37.46	29.54	5.07	5.52
Net Debt to NOPAT	4.30	4.07	4.19	3.94	33.71	36.08	35.90	28.30	4.85	5.30
Long-Term Debt to NOPAT	4.52	4.32	4.32	4.22	35.64	38.09	36.22	28.47	4.88	5.30
Altman Z-Score	2.66	2.82	2.58	2.78	1.88	2.32	2.42	2.15	1.99	1.46
Noncontrolling Interest Sharing Ratio	2.82%	2.80%	2.88%	2.89%	3.29%	3.35%	3.38%	3.33%	3.56%	3.67%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.30	1.30	1.42	1.34	0.81	0.67	1.27	1.18	1.07	1.00
Quick Ratio	1.02	1.08	1.08	1.06	0.53	0.52	0.96	0.85	0.76	0.76
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-446	-53	-216	-72	-20	103	-366	-430	-760	-852
Operating Cash Flow to CapEx	53.83%	138.36%	67.17%	180.72%	107.67%	105.79%	-240.93%	111.80%	85.76%	57.41%
Free Cash Flow to Firm to Interest Expense	-24.78	-2.72	0.00	-3.42	-0.98	0.00	-13.45	-14.74	-25.41	-28.33
Operating Cash Flow to Interest Expense	2.28	5.85	0.00	7.83	6.65	0.00	-11.81	5.87	5.45	3.88
Operating Cash Flow Less CapEx to Interest Expense	-1.96	1.62	0.00	3.50	0.47	0.00	-16.71	0.62	-0.91	-2.88
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.53	0.54	0.55	0.55	0.56	0.57	0.57	0.56	0.56	0.56
Accounts Receivable Turnover	8.45	8.65	8.36	8.60	8.43	8.56	8.17	8.32	8.36	8.68
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	1.42	1.40	1.42	1.41	1.41	1.39	1.37	1.34	1.29	1.23
Accounts Payable Turnover	13.36	13.71	12.60	11.49	11.56	12.06	11.34	10.58	9.48	8.70
Days Sales Outstanding (DSO)	43.17	42.21	43.66	42.45	43.29	42.62	44.68	43.89	43.64	42.05
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	27.33	26.63	28.96	31.76	31.56	30.28	32.18	34.49	38.48	41.96
Cash Conversion Cycle (CCC)	15.85	15.59	14.69	10.69	11.73	12.34	12.50	9.40	5.15	0.09
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	4,257	4,189	4,287	4,296	4,087	4,159	4,754	4,829	4,940	5,071
Invested Capital Turnover	0.63	0.63	0.65	0.66	0.69	0.70	0.66	0.67	0.69	0.68
Increase / (Decrease) in Invested Capital	527	126	298	161	-169	-30	467	533	853	912
Enterprise Value (EV)	8,615	8,866	8,045	8,704	7,855	8,548	9,193	8,142	7,798	5,681
Market Capitalization	7,102	7,489	6,597	7,330	6,481	7,171	7,305	6,266	5,889	3,683
Book Value per Share	$30.20	$30.92	$31.10	$31.74	$29.43	$30.17	$31.37	$31.83	$32.64	$33.09
Tangible Book Value per Share	$5.06	$5.65	$5.92	$6.81	$4.48	$5.23	$5.82	$6.66	$7.47	$7.95
Total Capital	4,350	4,287	4,351	4,408	4,187	4,259	4,831	4,906	5,023	5,148
Total Debt	1,518	1,386	1,421	1,396	1,377	1,372	1,856	1,841	1,877	1,957
Total Long-Term Debt	1,497	1,365	1,400	1,372	1,350	1,343	1,794	1,775	1,805	1,880
Net Debt	1,425	1,288	1,357	1,284	1,277	1,272	1,778	1,764	1,794	1,881
Capital Expenditures (CapEx)	76	82	66	91	128	110	133	153	190	203
Debt-free, Cash-free Net Working Capital (DFCFNWC)	48	41	117	58	-234	-361	113	88	32	0.08
Debt-free Net Working Capital (DFNWC)	142	139	181	170	-135	-261	190	165	114	76
Net Working Capital (NWC)	121	118	160	146	-161	-290	128	99	43	-0.43
Net Nonoperating Expense (NNE)	7.78	10	16	16	26	14	22	22	22	27
Net Nonoperating Obligations (NNO)	1,425	1,288	1,357	1,284	1,277	1,272	1,778	1,764	1,794	1,881
Total Depreciation and Amortization (D&A)	30	31	32	33	34	36	37	37	39	41
Debt-free, Cash-free Net Working Capital to Revenue	1.92%	1.59%	4.34%	2.09%	-8.19%	-12.31%	3.76%	2.88%	1.03%	0.00%
Debt-free Net Working Capital to Revenue	5.61%	5.33%	6.71%	6.13%	-4.71%	-8.90%	6.35%	5.41%	3.66%	2.42%
Net Working Capital to Revenue	4.77%	4.51%	5.92%	5.27%	-5.64%	-9.89%	4.29%	3.23%	1.36%	-0.01%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.79	$0.69	$0.73	$0.79	($2.39)	$0.63	$0.84	$0.86	$0.74	$0.35
Adjusted Weighted Average Basic Shares Outstanding	89.83M	89.68M	90.10M	91.04M	91.17M	90.95M	91.36M	91.63M	91.72M	91.62M
Adjusted Diluted Earnings per Share	$0.78	$0.65	$0.72	$0.79	($2.39)	$0.64	$0.83	$0.85	$0.74	$0.36
Adjusted Weighted Average Diluted Shares Outstanding	91.72M	91.56M	91.39M	91.55M	91.17M	90.95M	92.01M	92.04M	92.19M	92.06M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	90.98M	91.31M	92.03M	92.17M	92.22M	92.29M	92.77M	92.87M	92.89M	92.91M
Normalized Net Operating Profit after Tax (NOPAT)	89	77	87	103	94	100	103	108	107	86
Normalized NOPAT Margin	13.35%	11.43%	12.37%	14.09%	12.53%	13.45%	13.37%	13.61%	13.07%	11.13%
Pre Tax Income Margin	14.56%	13.04%	12.16%	13.19%	-38.30%	10.77%	12.87%	13.37%	12.08%	4.91%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	5.97	5.27	0.00	5.61	-13.07	0.00	4.63	4.65	4.29	2.26
NOPAT to Interest Expense	4.49	3.78	0.00	4.28	-9.15	0.00	3.69	3.53	3.11	2.00
EBIT Less CapEx to Interest Expense	1.73	1.04	0.00	1.28	-19.24	0.00	-0.27	-0.60	-2.06	-4.50
NOPAT Less CapEx to Interest Expense	0.26	-0.45	0.00	-0.05	-15.32	0.00	-1.21	-1.72	-3.25	-4.76
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.58%	0.36%	0.20%	0.77%	-28.35%	-32.61%	-177.65%	121.08%	1.58%	1.12%
Augmented Payout Ratio	3.12%	4.54%	16.93%	18.06%	-430.63%	-315.70%	-177.65%	123.67%	1.57%	1.12%

Frequently Asked Questions About Acadia Healthcare's Financials

When does Acadia Healthcare's financial year end?

According to the most recent income statement we have on file, Acadia Healthcare's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Acadia Healthcare's net income changed over the last 9 years?

Acadia Healthcare's net income appears to be on an upward trend, with a most recent value of $264.48 million in 2024, rising from $111.48 million in 2015. The previous period was -$15.66 million in 2023.

What is Acadia Healthcare's operating income?

Acadia Healthcare's total operating income in 2024 was $458.25 million, based on the following breakdown:

Total Gross Profit: $1.46 billion
Total Operating Expenses: $1.00 billion

How has Acadia Healthcare revenue changed over the last 9 years?

Over the last 9 years, Acadia Healthcare's total revenue changed from $1.83 billion in 2015 to $3.15 billion in 2024, a change of 72.4%.

How much debt does Acadia Healthcare have?

Acadia Healthcare's total liabilities were at $2.77 billion at the end of 2024, a 11.9% increase from 2023, and a 6.9% increase since 2015.

How much cash does Acadia Healthcare have?

In the past 9 years, Acadia Healthcare's cash and equivalents has ranged from $11.22 million in 2015 to $378.70 million in 2020, and is currently $76.31 million as of their latest financial filing in 2024.

How has Acadia Healthcare's book value per share changed over the last 9 years?

Over the last 9 years, Acadia Healthcare's book value per share changed from 23.48 in 2015 to 33.09 in 2024, a change of 41.0%.

Remove Ads

Related Companies

This page (NASDAQ:ACHC) was last updated on 4/15/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Acadia Healthcare (ACHC) Financials

Frequently Asked Questions About Acadia Healthcare's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Acadia Healthcare (ACHC) Financials

Annual Income Statements for Acadia Healthcare

Quarterly Income Statements for Acadia Healthcare

Annual Cash Flow Statements for Acadia Healthcare

Quarterly Cash Flow Statements for Acadia Healthcare

Annual Balance Sheets for Acadia Healthcare

Quarterly Balance Sheets for Acadia Healthcare

Annual Metrics and Ratios for Acadia Healthcare

Quarterly Metrics and Ratios for Acadia Healthcare

Frequently Asked Questions About Acadia Healthcare's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools